Drug Trial Radar · NCT00037752
Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates
Last checked: Nov 20, 2026Latest source record: May 21, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
436
Actual
Start
Sep 2002
Primary completion
Aug 2008
Study completion Aug 2008
Sponsor
- Lead sponsor
- University of TennesseeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- First posted
- May 21, 2002
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if sibutramine will decrease post-cessation weight gain and cigarette smoking in overweight and obese smokers who quit smoking.
Conditions
- Cardiovascular Diseases
- Heart Diseases
- Obesity
Interventions
SibutramineDrug
At the baseline study visit, participants in Group 1 will be given a one month supply of 5 mg/d of sibutramine and a 1-month follow-up visit will be scheduled. After a safety evaluation at the 1-month follow-up visit, participants will have their dose of sibutramine titrated to 10 mg/d, a 1 month supply of the medication will be given to participants, and a 2-month follow-up visit will be scheduled. After a safety evaluation at the 2-month follow-up visit, participants will receive a 1 month supply of sibutramine 10 mg/d and a 3-month follow-up visit will be scheduled. At the 3-month follow-up visit, the sibutramine will be discontinued and participants will be scheduled for 4- and 5-month follow-up visits.
Behavioral Smoking Cessation ProgramBehavioral
Both groups of participants will take part in a behavioral smoking cessation program.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Post-cessation weight changeTime frame: Measured at 1 year follow-up
- Smoking cessationTime frame: Measured at 1 year follow-up
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Tennessee Health Science Center
Memphis, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.